NCT07188935 - Glycemia and Antibiotic Efficacy in Diabetic Recurrent UTIs | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

June 20, 2025

Study Completion Date

June 20, 2025

Conditions

T2DM (Type 2 Diabetes Mellitus)

Interventions

DRUG

ciprofloxacin 500 mg tablet

Administration of oral ciprofloxacin 500 mg twice daily for 7-14 days for the treatment of recurrent urinary tract infections in patients with type 2 diabetes mellitus, following local and international guidelines.

Trial Locations (1)

52001

Al-Zahraa Teaching Hospital, Wasit, Iraq, Kut

All Listed Sponsors

lead

Al-Mustansiriyah University

OTHER